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Background: To determine the impact of body-mass factors (BMF) before radiotherapy and changes during
radiotherapy on the magnitude of setup displacement in patients with head and neck cancer (HNC).
Methods: The clinical data of 30 patients with HNC was analyzed using the alignment data from daily on-line
on-board imaging from image-guided radiotherapy. BMFs included body weight, body height, and the
circumference and bilateral thickness of the neck. Changes in the BMFs during treatment were retrieved from
cone beam computed tomography at the 10th and 20th fractions. Setup errors for each patient were assessed
by systematic error (SE) and random error (RE) through the superior-inferior (SI), anterior-posterior (AP), and
medial-lateral (ML) directions, and couch rotation (CR). Using the median values of the BMFs as a cutoff, the
impact of the factors on the magnitude of displacement was assessed by the Mann–Whitney U test.
Results: A higher body weight before radiotherapy correlated with a greater AP-SE (p = 0.045), SI-RE (p = 0.023),
and CR-SE (p = 0.033). A longer body height was associated with a greater SI-RE (p = 0.002). A performance status
score of 1 or 2 was related to a greater AP-SE (p = 0.043), AP-RE (p = 0.015), and SI-RE (p = 0.043). Among the
ratios of the BMFs during radiotherapy, the values at the level of mastoid tip at the 20th fraction were associated
with greater setup errors.
Conclusions: To reduce setup errors in patients with HNC receiving RT, the use of on-line image-guided
radiotherapy is recommended for patients with a large body weight or height, and a performance status score
of 1–2. In addition, adaptive planning should be considered for those who have a large reduction ratio in the
circumference (<1) and thickness (<0.94) over the level of the mastoid tip during the 20th fraction of treatment.
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Table 1 Patient characteristics before radiotherapy
Age (y)
Median (range) 53 (30–77)
Body weight (kilogram)
Mean (range) 66.9 (41–90.3)
Median 65
Body height (cm)
Mean (range) 166.2 (153–177)
Median 167.2
BMI













Mean ± SD (range) 55.2 ± 3.7 (48.1-62.9)
Thickness A (cm)
Mean ± SD (range) 16.3 ± 1.3 (14.2-17.9)
Circumference B (cm)
Mean ± SD (range) 48.4 ± 3.8 (42.2-57.2)
Thickness B (cm)
Mean ± SD (range) 14.5 ± 1.5 (11.8-18.4)
Circumference C (cm)
Mean ± SD (range) 41.9 ± 4.5 (33.7-50.6)
Thickness C (cm)
Mean ± SD (range) 13.6 ± 1.8 (11.0-17.6)
Abbreviation: BMI = body mass index; ECOG = Eastern Cooperation Oncology
Group; CCRT = concurrent chemoradiotherapy; SD = standard deviation.
Note: Level A was labeled on the mastoid tip, the same section as the junction
between the skull base and the 1st cervical vertebra. Level B was based on the
mandible angle, the same height as the junction between the 2nd to the 3rd
cervical vertebrae. Level C was drawn from the thyroid notch, the same as the
5th cervical vertebra.
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Radiation therapy (RT) is commonly used as part of mul-
tiple modality treatment for hand and neck cancer (HNC).
Intensity-modulated radiation therapy (IMRT) has be-
come increasingly popular because dose escalation to the
target can be done while sparing adjacent normal tissues
[1]. However, precise patient setup is essential for safe and
accurate delivery because IMRT results in steep dose gra-
dients. In HNCs, several factors such as the accuracy of
the immobilization device, change in body contours, and
tumor regression could lead to setup uncertainties during
RT. Causes might be independent or related to the others.
Nonetheless, all of these factors need to be minimized
with the use of special approaches. Image-guided radiation
therapy (IGRT) can be used to correct and quantify geo-
metrical uncertainties for daily setup [2]. Although setup
variations can be reduced when using on-line IGRT daily
[3,4], the widespread use of daily IGRT is not always feas-
ible in all clinical settings. Adaptive radiotherapy (ART) is
an approach used to correct for anatomic changes caused
by tumor shrinkage or body weight loss during RT [5].
However, increased medical costs, higher staff workload,
and higher radiation doses to the patients are inevitable.
As a result, there is a need to investigate suitable indica-
tions for ART for patients with HNCs.
There are few studies reporting on setup displacement
due to patient-related factors before and during RT
for HNC. The main patient-related factors are body-
mass factors (BMF) because these affect the stability of
immobilization. In addition, correlation between these
BMFs and quantification of setup errors remain to be clari-
fied. This study was done to determine the impact of BMFs
before and during RT on positioning displacement for pa-
tients treated for HNCs. We tried to find correlations be-
tween BMFs and the magnitude of daily setup errors. The
results can help physicians determine who should be con-
sidered for on-line IGRT before starting RT, and select
those who need ART to reduce setup displacement.
Methods
Patients
With the approval of the local institutional review board,
clinical and image data from a cohort of 30 patients
treated for HNCs between June 2008 and January 2013
at China Medical University Hospital were reviewed.
Twenty-one patients were treated for nasopharyngeal
carcinoma, 8 for oropharyngeal cancer, and 1 for hypo-
pharyngeal cancer. Their median age was 53 years
(range: 33–77). All patients received IGRT with daily
on-line kilovoltage imaging with weekly cone beam
computed tomography (CBCT) to correct the treatment
position. No patients had ART planning before a pre-
scribed dose of 50 Gy. The characteristics of these pa-
tients are listed in Table 1.Treatment planning
To enhance the accuracy of the daily irradiated position, all
patients were immobilized by a thermoplastic mask (U-
shaped Head and Neck Mask, Renfu Medical Equipment,
Guangzhou, China) from the bottom of the orbit to the
shoulder. Following fabrication of the immobilization de-
vice, simulation using a computed tomographic (CT) scan




Figure 1 Circumference and thickness measured across three
specified sections. Level A is labeled on the mastoid tip, the
same section as the junction between the skull base and 1st
cervical vertebra. Level B is based on the mandible angle, the
same height as the junction between the 2nd to the 3rd cervical
vertabra. Level C is drawn from the thyroid notch, the same as the
5th cervical vertebra.
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protocol with a 3-mm-slice thickness, and were obtained
from the upper orbit to 2 cm below the sternum. Marks
on the patients’ skin were drawn using setup lasers to facili-
tate an accurate daily position.
For patients receiving definitive RT, the clinical target
volume (CTV) was defined as the gross tumor volume
plus a margin of 1.0 to 1.5 cm. We followed the guide-
lines for the delineation of an elective nodal CTV [6].
The planning target volume (PTV) was extended 3 mm
from the CTV to account for treatment uncertainty. All
patients underwent IMRT plans consisting of 7 copla-
nar fields using 6-MV photons. The prescription dose
to the CTV was 50 Gy in 25 fractions followed by a
boost to 70–72 Gy to high-risk regions (tumor and in-
volved lymph nodes). All plans were carried out using
a commercial radiation treatment planning system
(Eclipse version 8.6, Varian Medical Systems Inc, Palo
Alto, California, USA).
Treatment verification
All patients were treated with IGRT with a Varian Clinac
iX linear accelerator (Varian Medical Systems, Palo Alto,
California, USA) equipped with an on-line On- Board Im-
aging (OBI) function including two-dimensional (2D) kilo-
voltage (kV) images and three-dimensional (3D) CBCT.
The technicians set up the patients on a couch in the
simulation room according to the marks drawn on their
bodies. On-line OBI images (2D kV images daily and 3D
CBCT weekly) were taken and sent to the station where
they could be registered to digitally reconstructed radio-
graphs from the treatment planning images. Two techni-
cians compared these paired images by correlating the
bony anatomy and corrected the difference by shifting the
couch translationally before treatment. Then, an attending
physician confirmed the corrected on-line images. Ana-
tomic reference landmarks included at least three visible
bony structures, the vertebra of the C-spine, nasal septum,
and mandible profile.Anthropometric measures of body-related factors
Patient-related factors consisted of performance status
(PS), age, and BMFs. PS was scored according to the
Eastern Cooperative Oncology Group. The BMFs in-
cluded body weight, body height, body mass index
(BMI), and circumference and thickness across three
specified sections of the head and neck (Figure 1). Level
A was labeled on the mastoid tip, the same section as the
junction between the skull base and the 1st cervical verte-
bra. Level B was based on the mandible angle, the same
height as the junction between the 2nd to the 3rd cervical
vertebrae. Level C was drawn from the thyroid notch, the
same as the 5th cervical vertebra.BMFs were recorded before RT and at the 10th and 20th
fractions during the RT course. Because the circumferences
and thicknesses at the three specified levels could not
be measured prospectively, the values were retrieved
retrospectively according to the CT simulation images
and CBCT images during treatment. For circumfer-
ences, we first brushed the body contour at a specified
section with a fixed thickness to generate a volume.
Then, the calculated volumes were divided by the con-
touring thickness to obtain get the values of the circum-
ferences. The thickness was measured as the maximal
transverse distance at the same section as the circum-
ferences. The BMI was calculated as weight in kilo-
grams divided by the square of height in m according to
the definition of the World Health Organization.
Patients were monitored weekly and toxicities were re-
corded according to the Common Terminology Criteria
for Adverse Events version 3.0. Ratios of the BMFs dur-
ing RT were calculated on the three levels. For example,
the ratio of the circumference on Section A at the 10th
treatment was the circumference at level A at the 10th
fraction divided by the pretreatment circumference.
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After image registration, quantification of alignment data
for daily OBI in the superior-inferior (SI), anterior-
posterior (AP), and medial-lateral (ML) directions, and
couch rotation (CR) for all patients were collected. For
each direction, the recorded setup displacements were
composed of two components, systematic errors (SE) and
random errors (RE). The SE was the deviation between the
simulated patient position and the average patient position,
while the RE was that which occurred between different
fractions. The detailed calculation for SE and RE was simi-
lar to that used by Remeijer et al. [7].
By analyzing all the alignment data before the 25 frac-
tions of treatment for each patient, the values of SE and
RE for all directions in each patient could be calculated.Statistical analysis
We used the Mann–Whitney U test to determine the
correlation between the magnitude of errors and
patient-related factors. The median values of the BMFs
were used as a cut-off to divide lower and higher
groups. We also used the Pearson correlation coefficient
to examine the association between the reduction ratio
of body weight and circumferences or thicknesses. In
addition, the same test was used to examine the relation
across the displacement in different directions. A two-
sided p value of < 0.05 was considered statistically sig-
nificant. All statistical analyses were performed using a
commercial software package (SPSS 13.0 for Windows,
Chicago, IL, USA).Results
Baseline clinical characteristics
The median values for various BMFs are listed in Table 1.
The mean displacements in the SI, AP, and ML directions
for all patients were 1.3 mm, 1.6 mm, and 2.2 mm, respect-
ively. The population SE was, 2.2 mm, 1.1 mm, and
1.6 mm and the RE, 1.5 mm, 0.9 mm and 1.1 mm for the
SI, AP and ML directions, respectively. Van Herk et al. [8]
suggested a CTV- PTV margin of 2.5 SE + 0.7 RE to ensure
that 90% of patients in a population receive a minimum cu-
mulative CTV dose of at least 95% of the prescribed dose.
Under this definition, the suggested CTV-PTV margins for
setup uncertainties in our patients were 3.4, 4.8 and
6.5 mm in the AP, ML and SI directions, respectively. The
population SE and RE for CR were 0.31 and 0.36 degrees,
respectively.
There was no correlation across the displacement
among the three translation directions. However, the SE
and RE for the CR showed an association with the ML-SE
(r = 0.49, p = 0.007 and r =0.44, p = 0.016).
We found the correlation was not significant between
the ratio of body weight and thickness at level A on theCBCT at the 20th fraction (r = 0.32, p = 0.081), which is
depicted in Figure 2. In addition, there was no correlation
between the ratio of body weight and circumference at
any level either at the 10th or 20th fraction.
Correlation between pretreatment body-mass factors and
setup displacement
Table 2 summarizes the association between the mean
values of setup displacements in the three translational di-
rections and the BMFs. Of the pretreatment factors, a
larger body weight was significantly correlated with a
greater AP-SE (p = 0.045) and SI-RE (p = 0.023), and a
longer body height was associated with a greater SI-RE
(p = 0.002). A PS score of 1 or 2 was associated with a
greater AP-SE (p = 0.043), AP-RE (p = 0.015), and SI-RE
(p = 0.043).
In addition, body height was associated with the CR-
SE (p = 0.033) and marginally correlated with the CR-RE
(p = 0.067). For patients with longer and shorter body
heights, the mean CR-SE was 0.22 ± 0.21 and 0.40 ± 0.25
degrees, respectively. The other pretreatment factors
such as age, and BMI, were not associated with the mag-
nitude of setup errors.
Correlation between reduction ratio of body-mass factors
during RT and setup displacement
The alignment data before the CBCT of the 20th frac-
tion were included when investigating the correlation
between the setup errors and the change of the BMFs.
Among the ratios of the BMFs during RT, the values at
each level were divided into lower and higher 50%. Com-
pared with the ratios of body weight, our result showed
certain BMFs can be more useful for initiating ART. At
the 10th fraction of CBCT, the ratio of the thickness at
level A was correlated with a greater ML-RE (p = 0.043),
whereas the ratio of the thickness at level B was associ-
ated with a greater ML-RE (p = 0.019) (Table 3). At the
20th fraction, the ratio of the circumference at level A
had a significant correlation with a greater AP-SE (p =
0.019), AP-RE (p = 0.019), and SI-SE (p = 0.025). The ra-
tio of the thickness at level A was significantly correlated
with a greater ML-SE (p =0.013), whereas it showed a
marginal impact with the SI-RE (p =0.05) (Table 4). The
remaining ratio of the BMFs had no impact on setup er-
rors (Additional file 1).
The ratio of the thickness at level A at the 20th frac-
tion was associated with a greater CR-SE (p = 0.009) and
CR-RE (p = 0.019).
Discussion
Several studies have investigated setup uncertainty in
HNC patients [9-13], which could change the dose distri-
bution to the target volume and organs at risk [9,12]. Cer-
tainly, IGRT and ART are two solutions for these
Figure 2 The association between the ratio of body weight and thickness at level A during the 20th fraction of cone beam computed
tomography (r = 0.32, p = 0.081).
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national Commission on Radiation Units and Measure-
ments report 62 [15], an inappropriate definition of the
CTV-PTV margin, accounting for organ motion and setup
uncertainties, may yield an underdose to the CTV. In order
to define this margin for HNC, organ motion could be
neglected, while variability due to inadequate setup or de-
formity must be carefully considered [11]. In clinical prac-
tice, extensive use of daily IGRT is not always possible
because of limited facilities in some countries as well as
concerns about increased daily doses to patients [14]. Be-
cause there is a lack of evidence regarding patients who are
vulnerable to setup uncertainty, we first reported the im-
pact of pretreatment patient-related factors on setup dis-
placement. Based on our findings, physicians can select
appropriate patients for IGRT, such as those with a large
body weight or height, or a PS of 1 or above. For patients
who are not able to have IGRT for certain reasons, a suffi-
cient CTV-PTV margin in a specific direction would be
required to minimize uncertainties. Currently in our de-
partment, PTVs are generated by adding a 3 mm margin
to corresponding CTVs; this study disclosed the inad-
equacy of this approach in certain directions for those
prone to setup uncertainty if withholding IGRT. Be-
cause there might be great variety in setup accuracy
among institutions and some geographical or racial dif-
ference in BMFs [16], an in-house report is imperative
to minimize uncertainties. The current study provided a
simple approach for this.
For patients receiving RT for HNCs, anatomical modifi-
cations due to tumor regression and body weight loss areeasily noted during the RT course. Most physicians plan
ART according to body weight changes or an unfitted
immobilization device. Meanwhile, the geometric change
of tumor volume and organs at risk should also be
assessed. Currently, guidelines based on scientific data for
initiating ART are still lacking. Although it has been sug-
gested that an ART plan not only improves dosimetric ben-
efits but also increases tumor control and quality of life
[17-19], it may increase costs to patients and the workload
of clinical staff. Our work is a pilot study correlating changes
in BMFs and the magnitude of setup displacements in
HNC. Accordingly, ART planning can be initiated to
minimize uncertainties for patients with a great reduction of
the circumference or thickness at the level of mastoid tip at
the 20th fraction of RT. Otherwise, widening of the CTV-
PTV margin in the three translation directions should be
done. For example, the margin in the SI direction could be
expanded up to 7.4 mm for those with large changes in
BMFs, according to the formula of Van Herk et al. [8].
Among studies of setup analyses according to time
trend, Mongioj et al. [10] investigated alignment data from
a cohort of 20 patients with nasopharyngeal cancer. They
found setup displacements showed no significant changes
as therapy progressed, but greater errors were observed
when the patient had severe weight loss or tumor node
shrinkage. In addition, grade 2 toxicities were associated
with great displacement along the AP and SI directions.
However, the change of BMFs was not correlated with the
setup data. In the future, more studies are essential before
these parameters during RT become a reference for initiat-
ing ART. In addition, investigations should be done to find
Table 2 Setup displacement (mean ± standard deviation in mm) in three translational directions according to lower
and higher 50% percentile of body-related factors before RT
Variable AP-SE AP-RE SI-SE SI-RE ML-SE ML-RE
Body weight
Lower 0.9 ± 0.5 0.8 ± 0.3 2.1 ± 0.9 1.2 ± 0.4 1.8 ± 0.8 1.1 ± 0.3
Higher 1.3 ± 0.6 0.9 ± 0.3 2.4 ± 1.0 1.8 ± 0.9 1.9 ± 0.6 1.0 ± 0.4
p value 0.045* 0.250 0.567 0.023* 0.436 0.461
Body height
Lower 1.0 ± 0.6 0.8 ± 0.3 1.9 ± 0.6 1.1 ± 0.3 1.8 ± 0.7 1.1 ± 0.3
Higher 1.3 ± 0.5 0.9 ± 0.3 2.6 ± 1.1 1.9 ± 0.9 1.9 ± 0.7 1.1 ± 0.4
p value 0.081 0.161 0.116 0.002* 0.250 0.838
BMI
Lower 1.0 ± 0.5 0.8 ± 0.3 2.2 ± 0.9 1.4 ± 0.7 1.7 ± 0.8 1.1 ± 0.3
Higher 1.3 ± 0.6 0.9 ± 0.3 2.3 ± 1.1 1.6 ± 0.8 2.0 ± 0.5 1.1 ± 0.4
p value 0.187 0.512 0.935 0.217 0.305 0.935
Circumference A
Lower 1.0 ± 0.5 0.8 ± 0.2 2.1 ± 1.0 1.4 ± 0.7 1.8 ± 0.8 1.1 ± 0.4
Higher 1.3 ± 0.6 0.9 ± 0.3 2.3 ± 1.0 1.6 ± 0.8 1.9 ± 0.6 1.0 ± 0.3
p value 0.345 0.345 0.775 0.461 0.624 0.267
Circumference B
Lower 1.0 ± 0.5 0.8 ± 0.3 2.1 ± 1.0 1.4 ± 0.7 1.7 ± 0.8 1.1 ± 0.4
Higher 1.3 ± 0.6 0.8 ± 0.3 2.4 ± 1.0 1.6 ± 0.8 2.0 ± 0.5 1.0 ± 0.3
p value 0.389 0.486 0.305 0.187 0.345 0.412
Circumference C
Lower 1.1 ± 0.5 0.8 ± 0.3 2.3 ± 1.1 1.4 ± 0.7 1.7 ± 0.8 1.0 ± 0.4
Higher 1.2 ± 0.6 0.9 ± 0.3 2.2 ± 0.8 1.6 ± 0.8 2.0 ± 0.5 1.1 ± 0.3
p value 0.486 0.567 0.967 0.345 0.250 0.683
PS
0 0.9 ± 0.5 0.7 ± 0.2 2.0 ± 0.7 1.2 ± 0.4 2.0 ± 0.6 1.1 ± 0.4
1-2 1.4 ± 0.6 1.0 ± 0.3 2.6 ±1.2 1.9 ± 1.0 1.6 ± 0.7 1.0 ± 0.4
p value 0.043* 0.015* 0.245 0.043* 0.072* 0.934
Abbreviation: AP = anterior-posterior, SI = superior-inferior, ML =medial-lateral, SE = systemic error, RE = random error, BMI = body mass index,
PS = performance status.
Note: asterisk represents statistical significance.
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changes in BMFs.
Generally, our study disclosed most patients had a reduc-
tion in BMFs with time. However, we found some patients
had a ratio of BMFs ≧ 1 during the RT course (shown in
Tables 3, 4, and Additional file 1), particularly at the
10th fraction of RT. One plausible reason is that shrink-
age of soft tissue after RT might lead to an insufficient
immobilization effect from the thermoplastic mask. As
a result, the credibility of the calculated values across
the three levels of the BMFs might be challenged be-
cause of displacement of the patient’s neck. In addition,
the effect of intravenous fluid overload on neck swelling
during concurrent administration of chemotherapyshould be investigated further. To circumvent the limi-
tations of the study, daily CBCT should be implemented
to verify the reproducibility of the BMFs.
Our study should be interpreted with several concerns.
First, circumferences and thicknesses were not obtained
prospectively by measuring the body with a ruler, but were
measured retrospectively from CT images. The absolute
values and the ratio of the BMFs might be inconsistent
with those acquired from direct measurement. According
to previous comparison tests in some patients, the max-
imal deviation between the two methods was less than 5%.
Thus, this approach can be applied in those institutions
ready to initiate the analysis. Second, errors due to ana-
tomical changes should be distinguished from those
Table 3 Setup displacement (mean ± standard deviation in mm) in three translational directions according to lower
and higher 50% percentile of body-related factors during RT (10th fraction)
Variable AP-SE AP-RE SI-SE SI-RE ML-SE ML-RE
rT (level A)
Lower (<0.98) 1.0 ± 0.6 0.8 ± 0.3 2.3 ± 1.2 1.6 ± 0.8 2.0 ± 0.6 1.2 ± 0.4
Higher (>0.98) 1.2 ± 0.5 0.9 ± 0.3 2.1 ± 0.8 1.4 ± 0.7 1.7 ± 0.7 1.0 ± 0.3
p value 0.193 0.294 0.854 0.423 0.224 0.043*
rT (level B)
Lower (<0.97) 1.1 ± 0.6 0.8 ± 0.2 2.2 ± 1.1 1.3 ± 0.5 1.8 ± 0.7 1.2 ± 0.4
Higher (>0.97) 1.2 ± 0.6 0.9 ± 0.3 2.3 ± 0.9 1.6 ± 1.0 1.9 ± 0.7 0.9 ± 0.3
p value 0.667 0.918 0.473 0.448 0.334 0.019*
rBW
Lower (<0.99) 1.2 ± 0.6 0.9 ± 0.2 2.2 ± 0.9 1.4 ± 0.5 2.0 ± 0.8 1.2 ± 0.4
Higher (>0.99) 1.1 ± 0.5 0.9 ± 0.3 2.2 ± 1.1 1.5 ± 0.9 1.8 ± 0.6 1.0 ± 0.3
p value 0.851 0.884 0.819 0.884 0.787 0.267
Abbreviation: rT = ratio of thickness, during-RT/pre-RT; rBW = ratio of body weight, during-RT/pre-RT; AP = anterior-posterior, SI = superior-inferior;
ML =medial-lateral; SE = systematic error; RE = random error.
Note: asterisk respresents statistical significance.
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cumvented by the approach reported by Mc Dermott et al.
[20]. They suggested using differences in images created by
subtracting the first localization image from that of subse-
quent fractions was an efficient way to qualitatively detect
anatomical changes during RT. Third, the median value
was taken as a cut-off for each measure to create two
groups for comparison. As a result, a lot of different groups
were created. To achieve more detailed stratification of the
BMFs, there is a need to conduct a study with large sample
size. Finally, our study did not report the impact of daily
CBCT on setup displacement, as well as the weekly dosi-
metric changes. Although tumor and soft tissue targets
could be assessed by CBCT, Li et al. [2] suggested thatTable 4 Setup displacement (mean ± standard deviation in m
and higher 50% percentile of body-related factors during RT
Variable AP-SE AP-RE SI-
rC (level A)
Lower (<1) 1.4 ± 0.5 1.0 ± 0.2 2.5
Higher (>1) 0.9 ± 0.5 0.7 ± 0.2 2.0
p value 0.019* 0.019* 0.0
rT (level A)
Lower (<0.94) 1.3 ± 0.6 0.9 ± 0.3 2.5
Higher (>0.94) 1.0 ± 0.5 0.8 ± 0.2 2.0
p value 0.325 0.325 0.4
rBW
Lower (<0.95) 1.2 ± 0.5 0.9 ± 0.2 2.5
Higher (>0.95) 1.1 ± 0.6 0.9 ± 0.3 2.0
p value 0.377 0.608 0.1
Abbreviation: rC = ratio of circumference, during-RT/pre-RT; rT = ratio of thickness, du
AP = anterior-posterior, SI = superior-inferior; ML =medial-lateral; SE = systematic err
Note: asterisk represents statistical significance.there were no statistically significant differences in align-
ment between 2D kV and 3D CBCT images in HNCs.
Thus, the consistency between setup errors for the bony
structure and the target could be established. Future stud-
ies should enroll more patients prospectively, and evaluate
subsequent dosimetric changes according to evolution of
the BMFs.
Conclusions
This study recommends on-line IGRT for patients with
HNC receiving RT who have a large body weight or height,
or have a PS score of 1–2. In addition, to deliver more ac-
curate dose to tumor and avoid extra dose to organs at risk
due to anatomical change, an adaptive planning should bem) in three translational directions according to lower
(20th fraction)
SE SI-RE ML-SE ML-RE
± 0.9 1.8 ± 0.9 1.6 ± 0.7 1.0 ± 0.3
± 1.0 1.2 ± 0.5 2.0 ± 0.6 1.1 ± 0.4
93 0.025* 0.101 0.854
± 1.2 1.7 ± 0.8 2.2 ± 0.6 1.1 ± 0.3
± 0.6 1.3 ± 0.7 1.5 ± 0.6 1.0 ± 0.4
61 0.050 0.013* 0.217
± 1.0 1.5 ± 0.5 1.8 ± 0.6 1.1 ± 0.4
±1.0 1.5 ± 1.0 1.9 ± 0.7 1.0 ± 0.3
93 0.334 0.790 0.608
ring-RT/pre-RT; rBW = ratio of body weight, during-RT/pre-RT;
or; RE = random error.
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circumference (< 1) and thickness (< 0.94) over the level of
the mastoid tip at the 20th fraction of treatment.
Additional file
Additional file 1: Table S1. Setup displacement (mean ± standard
deviation in mm) in three translational directions according to lower and
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